The global In Vitro Diagnostics (IVD) Quality Control market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on In Vitro Diagnostics (IVD) Quality Control volume and value at global level, regional level and company level. From a global perspective, this report represents overall In Vitro Diagnostics (IVD) Quality Control market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of In Vitro Diagnostics (IVD) Quality Control in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their In Vitro Diagnostics (IVD) Quality Control manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche Diagnostics (Switzerland)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Helena Laboratories (US)
Bio-Rad Laboratories (US)
Danaher (US)
Sero AS (Norway)
Randox Laboratories (UK)
Siemens AG (Germany)
Technopath Clinical Diagnostics (Ireland)
Ortho Clinical Diagnostics (US)
Sun Diagnostics (US)
Sysmex (Japan)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Serum/Plasma-based Products
Whole Blood-based Products
Urine-based Products
Other Quality Control Products

Segment by Application
Hospitals
Clinics
Research Institutes and Academic Institutes
Other